^{_{Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.}}

0635 - Fed’s Bowman speaks

Palantir Technologies Inc (PLTR)

-7.58%

Gapping down after its Q3 2025 earnings report. Adjusted earnings of $0.21 per share beat estimates of $0.17, while sales of $1.181 billion exceeded estimates of $1.092 billion.. The company raised its FY25 sales guide to $4.396 billion-$4.4 billion, above estimates of $4.17 billion, and guided Q4 sales of $1.327 billion-$1.331 billion. While Palantir’s Q4 sales guide beat estimates of $1.19 billion, it implies 61% year-over-year growth, which would mark a slowdown from 63% revenue growth reported for Q3 2025. Separately, the company signed an agreement to form a joint venture with Dubai Holding in the UAE.

Tesla Inc (TSLA)

-2.45%

Trading lower premarket after Norges Bank Investment Management (NBIM), a major Tesla shareholder and manager of Norway’s $2.1 trillion sovereign wealth fund, announced that it has cast a vote against Tesla CEO Elon Musk’s proposed $1 trillion pay package. NBIM attributed the decision to concerns over the package’s size, the possibility of dilution, and dependence on Musk. The decision adds pressure ahead of Tesla’s November 6 shareholder vote, as the board warns Musk could leave if the compensation plan is rejected. Additionally, sales of China-made Tesla vehicles declined by 9.9% year-over-year in October 2025.

Uber Technologies Inc (UBER)

-5.02%

Trading sharply lower premarket after its Q3 2025 earnings report. Adjusted earnings of $0.81 per share beat estimates of $0.69, while sales of $13.467 billion beat estimates of $13.275 billion. Gross bookings of $49.74 billion beat estimates of $48.73 billion, with adjusted EBITDA and trips growing by 33% and 22% year-over-year, respectively. Uber reported year-over-year growth in gross bookings, revenue, and adjusted EBITDA across both its Mobility and Delivery segments. The company guided gross bookings between $52.25 billion and $53.75 billion for Q4, above estimates of $52 billion.

NVIDIA Corp (NVDA)

-1.70%

The company has entered a €1 billion ($1.17 billion) partnership with Deutsche Telekom to launch an industrial AI cloud, set to go live in early 2026. The cloud will operate from a refurbished data center in Munich. Separately, a 13F filing for Michael Burry’s Scion Asset Management revealed bets against both Nvidia and Palantir in the form of put options.

Crypto Stocks

-2.05%

Trading lower as a group in tandem with declines in Bitcoin and Ethereum, both of which fell sharply on Monday and are poised to continue selling off on Tuesday. According to data from CoinGlass, 24-hour crypto liquidations reached $1.37 billion as of 4:45 AM ET. Bitcoin opened near the $110,500 level on Monday and is trading just below $104,000 as of 7:50 AM ET on Tuesday; Ethereum, meanwhile, has dropped from $3,900 to $3,500 over the same period.

CRCL, MSTR, COIN, IBIT, ETHE, HIVE, HUT, HOOD, MARA, RIOT, CLSK, BMNR

Shopify Inc (SHOP)

-3.43%

Trading sharply lower premarket following its Q3 2025 earnings report. Revenue grew by 32% year-over-year to $2.84 billion, above estimates of $2.75 billion, while adjusted earnings of $0.34 per share came in-line with analyst estimates. Gross merchandise volume (GMV) grew by 32% year-over-year to reach $92 billion, above estimates of $88.9 billion. The company expects Q4 25 revenue to grow year-over-year at a mid-to-high twenties percentage rate.

Hims & Hers Health Inc (HIMS)

+0.65%

Trading higher premarket after its Q3 2025 earnings report. Earnings of $0.06 per share missed estimates of $0.09, but sales of $598.976 million beat estimates of $580.241 million. Subscribers grew by 21% year-over-year, with monthly online revenue per average subscriber increasing by 19%. Hims & Hers guided Q4 sales between $605 million and $625 million, below estimates of $631.685 million. The company also announced that it is in active talks to offer Wegovy injections, as well as an oral Wegovy offering from Novo Nordisk, via its platform.

Amazon.com Inc (AMZN)

-1.22%

Mizuho raised its price target on the stock to $315 from $300 while maintaining an Outperform rating. The price target increase was attributed to solid Q3 results, upbeat AWS commentary, and Amazon’s new OpenAI partnership. The firm expects AWS growth to accelerate to 21.4% in Q4 and values the segment more highly, reflecting optimism that Amazon remains undervalued relative to its long-term growth potential. Amazon closed 4% higher on Monday following the announcement of a $38 billion partnership between AWS and OpenAI.

Pfizer Inc (PFE)

-0.68%

On watch after its Q3 2025 earnings report. Adjusted earnings of $0.87 per share beat estimates of $0.63, while sales of $16.654 billion beat estimates of $16.592 billion. Revenue for its Eliquis, Vyndaqel, and Nurtec/Vydura vaccine types grew on a year-over year basis, though Paxlovid and Comirnaty revenue declined by 55% and 20%, respectively. The company raised its adjusted EPS guidance for FY25 to $3-$3.15, compared to estimates of $3.04, while reaffirming its sales projections of $61 billion to $64 billion for the same period; the midpoint of its sales guide falls just below estimates of $62.879 billion.

Alphabet Inc (GOOGL)

-1.83%

On watch after YouTube TV proposed restoring Disney’s ABC and ESPN networks amid ongoing licensing disputes, following Disney’s request to bring back ABC for Election Day coverage. While YouTube said Disney can continue streaming news via YouTube channels, it urged a full restoration of both ABC and ESPN to avoid further customer confusion and disruption.

Spotify Technology SA (SPOT)

+4.95%

The company posted sales of $4.994 billion and earnings of $3.83 per share for Q3 25, beating estimates of $4.92 billion and $1.87, respectively. Monthly active users (MAUs) grew by 11% year-over-year, while premium subscribers grew by 12% and ad-supported MAUs grew by 11%. The company guided greater-than-expected MAUs and premium subscribers for Q4 2025.

Sarepta Therapeutics Inc (SRPT)

-34.19%

Gapping down after its Q3 2025 earnings report, during which the company announced that its ESSENCE study failed to achieve statistical significance with regards to its primary endpoint. The company reported adjusted losses of $0.13 per share, far narrower than the estimated loss of $0.81 per share, with sales of $399.356 million similarly beating estimates of $338.71 million. Approximately 19.15% of the stock’s float is sold short.

Denny’s Corp (DENN)

+50.12%

Gapping up after its Q3 2025 earnings report, during which the company announced it will be acquired in a ~$620 million all-cash deal. The deal, led by TriArtisan Capital, values Denny’s at $6.25 per share. Approximately 9.5% of the stock’s float is sold short.